Objectives: Prednisolone is a commonly used drug in cats and potential adverse effects include hyperglycaemia and diabetes mellitus. The aims of this study were to evaluate the frequency and investigate potential predisposing risk factors for the development of prednisolone-induced diabetes mellitus (PIDM) in cats. Methods: The electronic records of a tertiary referral centre were searched for cats receiving prednisolone at a starting dose of ⩾1.9 mg/kg/day, for >3 weeks and with follow-up data available for >3 months between January 2007 and July 2019. One hundred and forty-three cats were included in the study. Results: Of the 143 cats, 14 cats (9.7%) were diagnosed with PIDM. Twelve out of 14 cats (85.7%) developed diabetes within 3 months of the initiation of therapy. Conclusions and relevance: Cats requiring high-dose prednisolone therapy should be closely monitored over the first 3 months of therapy for the development of PIDM.
Background: Canine diabetes mellitus (DM) is a relatively common endocrinopathy, and it requires dedication and commitment from an owner to care for a diabetic pet. This study aimed to describe treatment and monitoring habits, perceived owner and veterinary concerns when treating and monitoring a diabetic dog, as well as triggers for and risk of euthanasia in diabetic dogs among Norwegian veterinarians. A questionnaire was designed and made available online. Results: A total of 125 veterinarians completed the survey. According to the data collected, the cumulative incidence risk for treatment initiation was 71.6% (95% CI 63.2, 80.6), suggesting that the respondents started most of the diabetic dogs seen in their practice on treatment. The majority of the respondents reported that all female entire diabetic dogs were neutered near the time of diagnosis. Main veterinary treatment concerns identified were difficulties in achieving rapid and adequate control. Main respondent-perceived owner concerns were cost and injecting their diabetic dog. About 60% of respondents had never used a continuous glucose monitor. Of respondents having used such monitors, half had experienced owners changing the insulin dose themselves, without consulting a veterinarian. Nearly one third of the veterinarians recalled that issues related to monitoring contributed directly to euthanasia of a diabetic dog in their care. The estimated one month and one year cumulative risk of euthanasia in dogs started on insulin therapy found in our study were 11.5% (95% CI 8.3, 14.6) and 26.9% (95% CI 22.0, 31.8), respectively. In our study population, respondents working in large cities were more likely to report a high probability of starting treatment than respondents in small cities and rural areas. Respondents in small cities and rural areas were also more likely to report medium and high risk of euthanasia compared to respondents in large cities, respectively. Veterinary-perceived owner triggers for euthanasia were dogs’ quality of life, monitoring, and owners’ lifestyle changes. For the respondents themselves, comorbidities were the leading factor reported for recommending euthanasia. Conclusions: This questionnaire-based study describes perceived treatment concerns, and reasons for and estimates of euthanasia risk in dogs with DM, based on the experiences of veterinary practitioners working in Norway. The results highlight important aspects of the treatment and monitoring of dogs with DM, as well as triggers for euthanasia. Further investigations into the aspects identified could be useful to improve the overall care for diabetic dogs.
Feline ascites has been reported to have a poor prognosis, with a median survival time of 21 days (considering all etiologies). However, previous studies included relatively small populations (<100 cases) and there is no literature evaluating the prognosis of all causes of feline ascites within the last 20 years. This study aimed to assess the survival times of a large population of cats presenting with ascites and assess the effect of the effusion cause, signalment, clinicopathological and imaging findings on survival. Data was acquired from the medical record system of a referral hospital (including both referrals and first-opinion emergency cases). Four hundred and ninety-eight cats met the inclusion criteria and 55% of all cases survived to discharge. Median survival time post-discharge was 30.5 days. The cause of the effusion was significantly associated with survival to discharge (p = 0.002). Common etiologies of ascites included neoplasia, septic peritonitis, sterile inflammatory disease, uroperitoneum, hemoperitoneum and cardiac disease. Uroperitoneum cases had the highest rate of survival to discharge (77%), while hemoperitoneum cases had the lowest percentage surviving to discharge (40%). Subjectively assessed effusion volume on imaging was significantly associated with survival to discharge (p = 0.012). Subjective assessment of the effusion volume and effusion assessment via abdominocentesis to help obtain a diagnosis can help guide prognosis and are diagnostics that do not require advanced techniques or specialist equipment, which can provide important prognostic information for cats presenting with ascites.